Spring til hovednavigation Spring til søgning Spring til hovedindhold

Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [ 68 Ga]PSMA-11-PET and [ 11 C]Acetate-PET

  • Kristina Sandgren
  • , Sara N Strandberg
  • , Joakim H Jonsson
  • , Josefine Grefve
  • , Angsana Keeratijarut Lindberg
  • , Erik Nilsson
  • , Anders Bergh
  • , Karin Söderkvist
  • , Camilla Thellenberg Karlsson
  • , Bengt Friedrich
  • , Anders Widmark
  • , Lennart Blomqvist
  • , Vibeke Berg Loegager
  • , Jan Axelsson
  • , Mattias Ögren
  • , Margareta Ögren
  • , Tufve Nyholm
  • , Katrine Riklund
9 Citationer (Scopus)

Abstract

OBJECTIVE: PET/CT and multiparametric MRI (mpMRI) are important diagnostic tools in clinically significant prostate cancer (csPC). The aim of this study was to compare csPC detection rates with [ 68 Ga]PSMA-11-PET (PSMA)-PET, [ 11 C]Acetate (ACE)-PET, and mpMRI with histopathology as reference, to identify the most suitable imaging modalities for subsequent hybrid imaging. An additional aim was to compare inter-reader variability to assess reproducibility.

METHODS: During 2016-2019, all study participants were examined with PSMA-PET/mpMRI and ACE-PET/CT prior to radical prostatectomy. PSMA-PET, ACE-PET and mpMRI were evaluated separately by two observers, and were compared with histopathology-defined csPC. Statistical analyses included two-sided McNemar test and index of specific agreement.

RESULTS: Fifty-five study participants were included, with 130 histopathological intraprostatic lesions >0.05 cc. Of these, 32% (42/130) were classified as csPC with ISUP grade ≥2 and volume >0.5 cc. PSMA-PET and mpMRI showed no difference in performance ( P  = 0.48), with mean csPC detection rate of 70% (29.5/42) and 74% (31/42), respectively, while with ACE-PET the mean csPC detection rate was 37% (15.5/42). Interobserver agreement was higher with PSMA-PET compared to mpMRI [79% (26/33) vs 67% (24/38)]. Including all detected lesions from each pair of observers, the detection rate increased to 90% (38/42) with mpMRI, and 79% (33/42) with PSMA-PET.

CONCLUSION: PSMA-PET and mpMRI showed high csPC detection rates and superior performance compared to ACE-PET. The interobserver agreement indicates higher reproducibility with PSMA-PET. The combined result of all observers in both PSMA-PET and mpMRI showed the highest detection rate, suggesting an added value of a hybrid imaging approach.

OriginalsprogEngelsk
TidsskriftNuclear Medicine Communications
Vol/bind44
Udgave nummer11
Sider (fra-til)997-1004
Antal sider8
ISSN0143-3636
DOI
StatusUdgivet - 1 nov. 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [ 68 Ga]PSMA-11-PET and [ 11 C]Acetate-PET'. Sammen danner de et unikt fingeraftryk.

Citationsformater